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The gut microbiota significantly regulates the development and function of the innate
and adaptive immune system. The attribute of immunological memory has long been
linked only with adaptive immunity. Recent evidence indicates that memory is also
present in the innate immune cells such as monocytes/macrophages and natural
killer cells. These cells exhibit pattern recognition receptors (PRRs) that recognize
microbe- or pathogen-associated molecular patterns (MAMPs or PAMPs) expressed by
the microbes. Interaction between PRRs and MAMPs is quite crucial since it triggers
the sequence of signaling events and epigenetic rewiring that not only play a cardinal
role in modulating the activation and function of the innate cells but also impart a
sense of memory response. We discuss here how gut microbiota can influence the
generation of innate memory and functional reprogramming of bone marrow progenitors
that helps in protection against infections. This article will broaden our current perspective
of association between the gut microbiome and innate memory. In the future, this
knowledge may pave avenues for development and designing of novel immunotherapies
and vaccination strategies.
Keywords: gut microbiota, macrophages, monocytes, innate immunity, innate memory

INTRODUCTION
The host immune system has the two major arms of protection. The first is innate immunity,
which is characterized by non-specific and rapid response against the infectious agent. The
second is adaptive, whose hallmark is specificity and memory (1). In the absence of adaptive
immune response, innate immunity takes charge of mounting a successful defense response in
many organisms (e.g., invertebrates, plants) including mammals (2). Innate immune memory is
an emerging concept initially coined by Netea and colleagues that defines the rapid protective
response of innate cells to heterologous infections (3–5). This is accompanied by the epigenetic
reprogramming that modulates their gene expression and metabolic state and thereby affects the
physiology and function of innate immune cells (6, 7). Notably, innate immune memory does not
lead to permanent changes in the genome of cells such as mutations and rearrangement of genes,
a characteristic of adaptive immune cells (T cells, B cells) (6). Recent findings showed the presence
of previously encountered memories even in the non-immune cells of the host (8, 9).
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provides current knowledge of gut microbial signatures and
their interaction with the innate cells in imparting them the
“memory” characteristics. It would be beneficial to develop
immunotherapies and vaccination strategies that can generate
memory features in innate cells to efficiently combat pathogens.
Here, we discuss and hypothesize the possible impact of gut
microbiota in inducing the beneficial innate memory response in
the host (Figure 1).

The key players mediating the communication of host
and microbes are the sensors, known as pattern recognition
receptors (PRRs), expressed by innate immune cells such as
dendritic cells (DCs), monocytes/macrophages, and natural
killer (NK) cells (10–13). These PRRs recognize microbe- or
pathogen-associated molecular patterns (MAMPs or PAMPs)
(14–16) PRRs mainly include the families of toll-like receptors
(TLRs), nucleotide-binding oligomerization domain (NOD)–like
receptors (NLRs), C-type lectin receptors (CLRs), and RIG-I–
like receptors (RLRs) (10, 11). The microbiota recognition via
these PRRs may induce the memory response upon primary
exposure (17, 18). This immunological memory in innate cells
has been associated with non-specific vaccination effects. For
instance, NK cells and monocytes derived from BCG-immunized
individuals displayed a heightened immune response upon restimulation and heterologous infections (19, 20). Further, there
is evidence of innate memory induction by polio and measles
vaccines in humans (21). However, much remains to be studied
in the context of gut microbiota–induced innate memory.
Gut microbiota has been established to be a crucial regulator
of immune cell development and function (10, 22). The gut
microbes and mammals have coevolved and cohabitated for
millions of years and exhibit a high degree of mutualism (23).
While the microbes get a habitat and nourishment from the
host, these microbes return the favor by regulating various
host physiological functions, including dietary digestion, and
imparting protective immunity against pathogens (24, 25).
Further, gut commensal–mediated competition for habitat site,
nutrients, or secretion of antimicrobial peptides aids in the
maintenance of homeostasis (26, 27). Additionally, signals
derived from gut microbes are suggested to tune the immune
cells for pro- and anti-inflammatory responses that may affect the
susceptibility to diseases (22, 28). Likewise, germ-free mice have
been shown to possess immune defects and impaired defense
systems (29).
In a healthy state, the immune system reacts against the
pathogenic microbes via activation of the inflammatory response,
while being tolerant of beneficial microbiota (24, 30). For
instance, bacterial phyla such as Bifidobacteria and Lactobacillus
are considered beneficial and thus classified as “symbionts.”
On the other hand, few species of Escherichia coli are viewed
as opportunistic pathogens (pathobionts) (31, 32). Thus, the
intestinal immune system requires a careful surveillance system
to constantly monitor the flora communities in the lumen
for maintaining the host defense. It is well-documented that
T cell homeostasis and differentiation and their function are
extensively modulated by the gut bacteria (33). For example,
Bacteroides fragilis and segmented filamentous bacteria (SFB)
have been reported to induce Tregs and Th17 cell differentiation,
respectively, in the intestine, thus affecting the host response
to infections (34, 35). It is still unclear how the gut microbial
population, and its components, could reprogram the innate
immune cells to exhibit memory responses.
Given the importance of gut microbiota, characterization
and understanding of the involved microbial factors that
determine the innate immune memory response is crucial for
constructing novel therapeutic interventions (3, 7). This review

Frontiers in Immunology | www.frontiersin.org

PROSPECTIVE LINK BETWEEN GUT
MICROBIOTA AND INNATE IMMUNE
MEMORY
The presence of microbiota-derived ligands/products/
metabolites affects the differentiation and function of myeloid
and lymphoid lineage innate cells via PRRs (36–38). Innate
immune memory has been seen to be an attribute of myeloid
cells (monocytes/macrophages), innate lymphoid cells (ILCs)
including NK cells, and bone marrow progenitors (39). It is
mediated by the transcriptional changes in genes or a specific
locus and epigenetic rewiring of these cells upon the primary
exposure (39). Consequently, the secondary response to the
subsequent infections is enhanced, rapid, and nonspecific
(Figure 2). This phenomenon also exists in the bone marrow
progenitors, indicating the systemic effects of gut microbiota
(40), and the induced memory may persist from weeks up to
months (20, 41).
Training of PRRs expressing innate cells with gut
microbial/non-microbial ligands is required as a protective
mechanism independent of adaptive immunity during
secondary infection/pathogenic exposures (42). For instance,
administration of unmethylated CpG oligodeoxynucleotides
prior to infection confers protection in a sepsis and meningitis
model (43). Further, polysaccharide β-glucan has been reported
to impart defense against Staphylococcus infection (44, 45).
Other microbial components such as peptidoglycan that are
expressed on numerous bacteria generate innate memory in
Toxoplasma infection (46). In addition, cytokines such as IL-18,
IL-12, IL-6, IL-23, IL-1β, and IL-15 have been demonstrated to
generate memory response in innate cells (47, 48). Several studies
established the existence of NK cell memory that leads to their
increased activation upon second stimulation (43, 48). Moreover,
DCs from protectively immunized mice demonstrated memory
response against a fungal pathogen. These DCs showed increased
IFN signaling pathway activation and specific histone (H3K4me3
and H3K27me3) modifications (49).
Importantly, commensals in the gut are involved in the
production of immunomodulatory metabolites that comprise
short-chain fatty acids (SCFAs) such as butyrate, acetate, and
propionate (50–52). Further, commensals such as Bacteroides,
Lactobacillus, and Bifidobacteria synthesize secondary bile acids
that are derived from the metabolism of primary bile acids (53–
55). Binding of these bioactive molecules to the receptors on the
innate cells regulate their metabolism and functions (51, 56).
SCFAs serve as inhibitors of histone deacetylases (HDACs) in
innate cells such as DCs and macrophages (57–59). Moreover,
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FIGURE 1 | Schematic illustration of gut microbiota as potential inducer of innate memory. The gut microbial products serve as a source of microbe-associated
molecular patterns (MAMPs) that bind pattern recognition receptors (PRRs) on innate cells such as monocytes/macrophages and natural killer (NK) cells. Further, this
cell activation is accompanied by the epigenetic and metabolic reprogramming which is responsible for their increased cytokine release and heightened immune
response upon the subsequent pathogenic exposure. Moreover, these microbial ligands reach the bone marrow through blood circulation and condition the
hematopoietic progenitors to induce long-term memory traits and enhance myelopoiesis for mounting the beneficial inflammatory response during systemic infections.

it was shown that SCFAs boost the population of myeloid
precursors, resulting in protection against infection (60, 61).
Additionally, secondary bile acids are known to modulate gut
microbial composition (62). Further, they influence the function
of innate cells by inhibiting NF-κB activation (63, 64). These
findings suggest the possible epigenetic regulation of these cells
via metabolites in the process of innate memory formation.
Emerging evidence suggests that diet-induced microbial
changes in the gut could lead to the long-lasting rewiring of
the innate cells. Interestingly, western diet (WD) has been
linked to enhanced innate immune response. It is shown
to induce epigenetic and transcriptional reprogramming of
myeloid progenitors via the NLRP3 inflammasome and IL-1R
signaling (65). In this case, WD-induced dysbalanced cholesterol
biosynthesis led to the accumulation of mevalonate, which is
implicated in the generation of innate memory. Indeed, a few
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studies indicate that maternal diet during pregnancy can have a
pronounced effect in shaping the offspring microbiome (66, 67).
Further, the gut may be a source of bacteria present in breast
milk (68, 69). Of note, microbial exposure during pregnancy
enhances the ILC3 and F4/80 (+) CD11c (+) mononuclear cell
population in the gut of neonates along with the reprogramming
of their intestinal transcriptional profiles. This effect is attributed
to the transfer of maternal antibodies that retains the microbial
signatures (70). In addition, infections during pregnancy can
induce maternal immune activation (MIA), which can lead to
the generation of immune cells with “memory” phenotype via
epigenomic changes (71, 72). This can result in the condition
of hyperimmune activation and neuropsychiatric diseases later
in life.
Apart from the diet, stress is another emerging factor that
can elicit innate memory phenotype (73, 74). Host cells secrete
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FIGURE 2 | Representative model of innate immune memory response. After initial exposure to gut microbial components, innate cells with “memory” traits respond
rapidly with high magnitude of immune response to the secondary stimulation.

specifically, the activation and expression of inflammatory genes
take place many times higher than the basal level. This happens
via the enhanced accessibility of DNA to enhancers/promoters,
increased histone methylation, and acetylation along with
enzyme RNA polymerase activity (81). These events are
accompanied by transcription factor (NF-κB, STAT molecules,
AP-1) translocation and activation (82–84). After the initial
exposure to microbial ligands, DNA methylation/histone
modifications continue to trigger rapid response upon reexposure. Further, various immunological pathways such as
STAT1, JNK, and MAPK are activated in the process of innate
memory generation. For instance, MAPK activates the ATF7
transcription factor and decreases the repression of histones
by recruiting the histone H3K9 dimethyltransferase (85).
For instance, BCG changes the transcriptional signatures of
hematopoietic stem cells (HSCs) to promote myelopoiesis and
generate more potent macrophages that can protect against
subsequent Mycobacterium tuberculosis infection (9). Of interest,
a diet enriched in low-density-lipoprotein cholesterol such as
WD elicits the expansion of HSCs along with the reprogramming
of granulocyte monocyte precursor cells (GMPs) through the
activation of NLRP3 inflammasome and possibly includes gut
dysbiosis (65).
Importantly, cells with innate memory were reported to
exhibit increased size, granularity, and activated phenotype
(86). They are usually deprived of acetylation and lack
active transcription. However, their inflammatory cytokine
gene promoters are marked with histone methylation (H3K4),
conferring them the attribute of rapid response upon re-exposure
(87). These epigenetically rewired innate cells may be sustained

an array of small molecules upon stress or any cellular damage
that can activate PRRs (75). These molecules, termed dangerassociated molecular patterns (DAMPs), resemble PAMPs and
thus are potential inducers of innate immune memory in cells
(75). Social stress also releases IL-6, IL-1β, and TNF-α cytokines
(73). Exposure to stressors has been demonstrated to trigger gut
microbe–mediated release of MAMPs in blood circulation (76).
Further, stressors implicate modification of H3K9 histones and
the activation of transcription factor ATF7 (77).
Gut microbiota has been reported to play a key role in
the induction of innate immune memory and protect against
infections in both vertebrates and invertebrates (78, 79). These
robust, non-specific memory effects mediated by MAMP–
microbiota interaction may contribute to the development
of effective vaccines and therapies that rely on boosting the
host innate defense. Understanding the phenomenon and the
involved mechanisms can be utilized to train these innate cells
and enhance their function against pathogenic infections in the
host. Further, this would aid the design and development of novel
therapies to treat diseases (80).

MECHANISMS OF INNATE MEMORY
INDUCTION BY MICROBIAL
COMPONENTS
Recent studies have highlighted the array of mechanisms
through which microbes imprint memory phenotype in innate
cells. Transcriptional changes are the hallmark of memory
imprints in innate cells, which involve chromatin modifications;
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antimicrobial peptides, e.g., defensins (97); regenerating isletderived protein 3 gamma (RegIIIγ) release by Paneth cells (98);
secretory IgA (99); and inhibitory TLR signaling (100–102).
Further, the PRR expression is context-dependent and varies
in cell types to control the deleterious inflammatory response
(16, 103). Interestingly, it is seen that the administration of
Lactobacillus plantarum protected well against viral infections
(104, 105). Further, there is emerging evidence that gut
microbiota is known to affect innate memory phenotype at the
distant mucosal sites or peripheral tissues. Yao et al. reported the
immunological memory phenotype and protective functions in
alveolar macrophages after respiratory virus infection (106).
In the context of memory, initial stimulation of innate cells
by MAMPs serves as a factor for “priming” and functionally
reprogramming of these cells to mediate heightened non-specific
response to subsequent pathogenic exposure (39). Gut microbial
components, mainly peptidoglycan, flagellin, β-glucan, and
lipoproteins, may induce memory phenotype in the innate cells,
which could underline their potential as an effective adjuvant for
vaccination studies (107, 108).
Peptidoglycan: It is an important component of the bacterial
cell membrane envelope, not present in the eukaryotic host. It
is found in both gram-positive and gram-negative commensals
(109). Further, the synthesis of peptidoglycan is ubiquitous in gut
bacteria that is recognized by NOD receptors (110). For instance,
NOD-1 binds only γ-d-glutamyl-meso-diaminopimelic acid
(DAP)–containing muropeptides, whereas NOD-2 recognizes
the MDP component (34). Further, a report demonstrated
that NOD-2 induced H3K4me3 epigenetic modification in
monocytes, a feature linked to innate memory (111). Moreover,
NOD receptor activation triggers the inflammasomes to secrete
cytokines such as IL-1β and IL-18, which is implicated in memory
generation (112).
Flagellin: It is the essential component of many commensals
and pathogens that activates TLR-5 signaling on innate cells
(113). CD103+ DCs in the intestine recognize flagellin and
secrete IL-23, which in turn triggers the ILCs to secrete IL-22 and
thus facilitates innate defense (114).
β-glucan: This cross-linked glucan particle is commonly
found in fungi and some bacterial cell walls (115). It is reported
to induce long-term memory response in macrophages and bone
marrow progenitors (40). This is accompanied by accumulation
of metabolite mevalonate and Warburg effect in innate cells
(91, 93). β-glucan is known to bind dectin-1 receptor (44, 116).
LPS: It is a glycolipid majorly found in the outer membrane
of gram-negative bacteria and induces activation of TLR-4
and downstream NF-κB signaling (117). Earlier studies have
shown that pretreatment with LPS prevents subsequent infection
(118, 119). Further, LPS derived from gut microbes such as
Bacteriodetes species is a potent activator of innate response
(120), although the dose of LPS is a crucial factor to determine the
induction of either memory or tolerant phenotype in cells (86).
Amongst the PRRs, TLRs are the most extensively studied
transmembrane or intracellular glycoproteins that recognize a
variety of microbial ligands or MAMPs as discussed above (10,
11). TLRs trigger signaling pathways, which leads to the secretion
of cytokines and gene transcription in monocytes/macrophages

in the host niche as seen in the case of NK cells and monocytes
(40, 88). Interestingly, microbiota absence in mice impaired
the histone modification in NK cells, rendering them unable
to trigger a protective inflammatory response against viral
infection (78).
Interestingly, various cellular metabolic pathways are involved
in triggering and maintaining these epigenetic modifications
(89, 90). Induction of memory features by β-glucan (microbial
polysaccharide) is accompanied by a metabolic shift to aerobic
glycolysis; this is referred to as the “Warburg effect” (91).
Several studies reported that genes of the mTOR-HIF1α pathway
were induced in β-glucan triggered monocytes that have
undergone epigenetic changes, i.e., H3K4me3 and H3K27ac
(7, 91). Moreover, TCA cycle metabolites such as mevalonate,
succinate, and fumarate induce the activation of genes required
to generate innate memory (92, 93). The pathway of cholesterol
synthesis and mevalonate through the activation of IGF1
receptor and mTOR and further enrichment of histone H3K4me3
generated innate memory (93). There are also studies indicating
the metabolic shift that leads to enhanced aerobic glycolysis,
cholesterol synthesis, and NAD+/NADH ratio in cells (7,
91). Further, another metabolite, acetyl-CoA, has been shown
to induce histone acetylation of genes related to glycolytic
enzymes, such as phosphofructokinase, hexokinase 2, and
lactate dehydrogenase (LDH), thus increasing glycolysis and
inducing memory phenotype (94). In fact, β-glucan has also
been shown to access bone marrow and act on myeloidbiased long-term HSCs (40). It is accompanied by changes in
lipid metabolism, IL-1β signaling, and activation of the GMCSF/CD131 axis. This β-glucan–mediated training is sufficient
to protect against secondary challenges and recover from
chemotherapy-induced myelosuppression.
The occurrence of innate immune memory relies on factors
such as dose/amount and duration of initial inflammatory
stimulus or PAMP. For example, a single low dose of
lipopolysaccharide (LPS) was able to induce more release
of proinflammatory molecules upon re-exposure and thus
induce innate memory (86). In another study, a similar
phenomenon was observed via epigenomic changes such as
histone H3K4me1 modification. On the contrary, four-time
administration of LPS led to the tolerant phenotype in
cells (95). Moreover, Ifrim et al. reported that moderate to
high doses of PRR ligands such as flagellin (10 µg/ml), LPS
(100 µg/ml), and poly I:C (100 µg/ml) led to tolerance (86).
On the contrary, a low to moderate dose of β-glucan (1 µg/ml)
and muramyl dipeptide (MDP) (10 µg/ml) was able to elicit
memory generation.

PRR MEDIATED REGULATION OF INNATE
MEMORY BY GUT MICROBIOTA
Gut microbiota is a source of ligands that serve as MAMPs
and activate innate cells expressing PRRs. In the homeostatic
condition, the aberrant PRR activation is limited by various
mechanisms such as the mucus layer (96); secretion of
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GUT MICROBIOTA INFLUENCES
FUNCTIONAL REWIRING OF BONE
MARROW PROGENITORS

and bone marrow progenitors (10). Triggering of TLR-2 by
microbial lipoteichoic acids, lipoproteins, lipopeptides, and
glycolipids activates NF-κB and is known to impart protection
in intestinal acute inflammation (121). Additionally, initial
priming of macrophages with TLR-2 and NOD-2 has been
shown to confer protection against acute infection (105). This
rapid response to continuously exposed mucosal tissue appears
to be an essential part of host defense. In addition, a study
demonstrated that stimulation of TLR-3 on macrophages with
dsRNA could lessen the symptoms of DSS-induced colitis (122).
Another study demonstrated the protective response in colitis
upon TLR-3 activation by dsRNA of lactic acid–producing
commensals (123).
In a healthy intestine, sensing of microbial LPS by TLR4 is required to defend against invading pathogens (14).
At homeostasis, there is a low level of TLR-4 expression,
which gets elevated in inflammatory conditions and diseases.
This results in the activation of innate immunity to restrict
pathogenic exposure (124). Moreover, TLR-5 binds the
flagellated bacteria and imparts protection to Enterobacter
and Salmonella infections in the host (125, 126). Furthermore,
another intracellular receptor, TLR-9, binds to the unmethylated
CpG dinucleotides, which are abundant in commensals
(127). TLR-9 activation stimulates the secretion of many
proinflammatory cytokines including IL-12, which is
considered a crucial cytokine to induce innate memory
phenotype. Notably, it is the pathogenic microbe, not
commensals, that breaches the gut lining and activate the
basolateral TLR-9 receptor (128, 129). Notably, host genetic
variations in the microbiota composition and pathogenic
exposure could impact the commensal-mediated immune
memory induction.
Another important class of PRRs involved in the education of
innate cells is intracellular NLRs (130). Interestingly, commensal
recognition by NLRs maintains homeostasis in the gut, while
the pathogenic species of Salmonella and Helicobacter pylori
trigger the inflammatory response (131, 132). NOD-1 and NOD2 expressed in monocytes/macrophages are known to recognize
microbial peptidoglycans DAP and MDP, respectively (34). NLR
activation initiates the signaling pathways such as p38, MAPK,
and NF-κB and elicits the release of cytokines (such as IL-1β
and IL-18) that are known to induce innate memory phenotype
(47, 48, 133). A study revealed that gut microbiota–derived
peptidoglycan enhanced the pathogen-clearing capacity of bone
marrow–derived neutrophils. The MDP fragments from the gut
translocated to the bone marrow and triggered the neutrophil
activation via NOD-1 signaling (134). This raises the possible
hypothesis that gut microbial components reach peripheral sites
and affect their epigenetic programming to imprint the memory
phenotype (40).
Noticeably, these PRRs’ stimulation may also lead to the
tolerogenic phenotype, but this relies on the nature and duration
of exposure to the initial microbial stimuli (135). Thus, these
PRRs mediated modulation of innate cells should be monitored
and utilized to generate the protective memory phenotype and
ultimately the rapid, heightened, and efficient response against
invading pathogens.
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The impact of microbiota in the immediate sites of
colonization such as the intestine, skin epithelium, and
respiratory mucosa is quite plausible (27). However, its
role in the primary site of hematopoiesis (bone marrow)
may have significant immunological relevance. Long-term
innate immune memory can be apparent in either the
persistence of reprogrammed monocytes/macrophages in
different tissues or modulation of bone marrow progenitors.
This can be easily hypothesized, from the fact that LPS
treatment in germ-free mice led to an elevation in the level
of inflammatory cytokines and neutrophil recruitment and
thus imparted systemic immunity (118). Concordantly,
microbiota-derived peptidoglycan trigger NOD-1 receptor in
peripheral blood neutrophils and boosted their anti-bacterial
activity (134).
Monocytes, macrophages, and DCs that play a crucial
role in shaping the immune response fall under myeloidderived cells. Myeloid-derived cells originate in the bone
marrow and then populate all lymphoid and non-lymphoid
tissues. The myeloid cellular system has a non-redundant
capacity to act in concert during the elimination process of
pathogens and re-establishing tissue integrity (136). Recent
reports demonstrated that gut bacteria, especially gramnegative bacteria, regulate granulopoietic events (137–140).
Goris et al. showed that germ-free and polymyxin-treated
mice have a lower number of bone marrow progenitor
cells (141). Further, these germ-free mice complemented
with fecal matter from wild type showed the reversion of
the myelopoiegenic capability of precursors in generating
colony-forming unit–granulocyte/macrophage (CFU–GM)
colonies (142).
Interestingly, naïve mice with bone marrow transferred from
the SFB and Clostridium spp. colonized mice demonstrated
protection from Entamoeba histolytica infection. This is
due to the expansion of marrow GMPs and increased
expression of the epigenetic mediator JMJD3 in GMPs.
SFB also altered the bone marrow DCs such that they
have an enhanced capacity to secrete IL-23 (143). Further,
adoptive transfer of DCs from SFB-supplemented mice
to SFB-deficient mice was sufficient to protect against E.
histolytica infection (143). Additionally, IL-1β and GM-CSF
cytokines released from peripheral sites have been shown
to confer the innate memory trait to the bone marrow
cells (40, 65, 144).
The F4/80hi macrophages have an embryonic origin, while
F4/80lo leukocytes have a hematopoietic origin (145, 146).
To test the contribution of gut microbiota in the promotion
of myelopoiesis, germ-free and specific pathogen–free (SPF)
′
mice were administered a thymidine analog, 5-ethynyl-2 deoxyuridine (EdU). In comparison to SPF mice, germ-free
mice showed reduced uptake of EdU in both F4/80hi and
F4/80lo phagocytes (61). This observation highlighted that
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NOD-1 receptor in IECs. This event is accompanied by
the production of defensin molecule and chemokine CCL20
secretion, which compel the generation of isolated lymphoid
follicles (ILFs), which are the site of B cell recruitment
and immune response generation (162). Moreover, there are
intestinal mononuclear phagocytes (iMPs), residing in the
intestinal sub-epithelium (163). Although the ontology of iMPs
is still in debate, they comprise macrophages and DCs that
regulate intestinal homeostasis (164). It is possible that these cells
with copious expression of several PRRs upon stimulation by
gut microbial components get memory signatures and persist in
secondary organs.
Intestinal epithelial stem cells (IESCs) are crucial cells in
the gut that have the capacity to differentiate into IECs. Gut
microbiota composition has a significant impact on the IESC
activity and renewal of intestinal epithelium, which is located
at proximity to the lumen (165). Interestingly, SCFAs such as
butyrate serve as a source of energy for IECs in metabolic
processes and act to inhibit HDAC activity in IESCs (166, 167).
Although it not very conclusive as of now to state the particular
species of bacteria that is specifically responsible for such
regulation, it is clear that some microbial metabolites stimulate
the Wnt/β-catenin pathway and maintain the IESCs (168). Other
signaling pathways, namely the JAK and STAT pathways, are very
important in the bacteria-modulated epithelium homeostasis
via stem cell regulation (165, 169, 170). These cells may
serve as the potential niche for the generation of long-term
innate memory.

commensals play a prominent role in the preservation of both
the HSC-derived myeloid and splenic yolk sac–derived cells
along with the inflammatory monocytes (145, 147). Further,
NOD-1 is known to be responsible for mediating myeloid
cell longevity. A study has shown decreased levels of NOD1 ligand (DAP) in mice with antibiotic-altered microbiota,
and upon NOD-1 stimulation, they found an abundance of
IL-17–secreting lymphocytes in the intestine, which relay the
microbial detection for systemic control of the phagocyte life
span (148).

CROSS TALK OF GUT MICROBIOTA AND
ILCs
ILCs are known as the subset of innate leukocytes of lymphoid
morphology that are mainly located in the mucosa. They lack
antigen-specific rearranged receptors and have been grouped
into NK cells and three classes as ILC1, ILC2, and ILC3
based on the type of cytokines they produce (149). Nonspecific memory NK cells generated upon cytokine stimulation
have been shown to exhibit a strong immune response
to infections.
Amongst ILCs, group 3 ILCs have a key role in the innate
immune response to invading pathogens in the gut. They
are the prominent source of IL-22 and other antimicrobial
proteins (AMPs) in the lamina propria of the intestine. IL22 binds to receptors present on the intestinal epithelial cells
(IECs) and induce the secretion of AMPs (RegIIIγ and RegIIIβ),
which eventually limit the colonization of pathogens such
as Citrobacter rodentium (150–152). Further, the functions of
ILC3 are influenced by the gut microbial metabolites (153).
Gut microbiota also aids in the conditioning and development
of ILCs (154, 155). Further, germ-free and antibiotic-treated
mice have a relatively diminished subset of NCR+ RORγt+
ILC population (156–158). A recent study revealed that TLR2 agonists can directly bind to human RORγt+ ILC, inducing
the secretion of IL-2, which further triggers the release of IL22, a cytokine known to be implicated in antimicrobial defense
(159). It would be interesting to see whether the interaction
between gut microbiota and these ILCs imparts them the
memory traits.

FUTURE DIRECTION AND CONCLUDING
REMARKS
The development of non-specific innate immune memory
appears to be a crucial evolutionary phenomenon to
benefit and protect the host against a variety of pathogens.
Gut microbiota performs the intricate function of
immune system maturation in neonates (171). Thus,
the induction of memory in innate cells during this
process appears to be a part of the host–microbiome
co-adaptation to mediate a prompt response to the
infectious stimulus.
It is evident that there would be circumstances in which
the innate memory can lead to the deleterious systemic
inflammatory response. If that persists for a long time, and
activates innate cells in conditions such as sepsis, it can lead
to tissue damage or immune paralysis. Further, the differential
generation of innate memory in various organs, its duration
in various immune cells, and the signaling pathways induced
by gut microbial components need to be investigated in
the future.
In conclusion, the process of innate memory generation
should be considered as an effective approach to boost
host defense and well-managed to minimize side effects
while being favorable to the host. Beneficial commensals
or derived products that induce the effective innate

IECs AS A MEDIATOR OF MICROBIOTA
AND IMMUNE CELL INTERACTION
IECs stand as a single-cell barrier between the intestinal
microbiota and the submucosal immune cells. When the IEC
barrier senses microbial pathogens, it reinforces its integrity
and thus protects against pathogen invasion (160). IECs
expressing TLRs are stimulated by commensal-derived ligands,
triggering the release of proinflammatory cytokines such as IL6 and TNF-α (14). Further, gut-derived metabolite butyrate
binds the IECs and triggers the innate sensors such as
NLRP3 inflammasome to secrete IL-18 (112, 161). Commensal
bacteria–derived peptidoglycan has been shown to trigger
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memory with regulated inflammatory response can be
utilized as potential novel therapeutics to treat infections
and diseases.

FUNDING

AUTHOR CONTRIBUTIONS

This study was supported by the Council of Scientific and
Industrial Research (CSIR) and Department of Biotechnology
(DBT), India.

SNe and JA contributed to the conception of the idea, design,
and conceptualization of the manuscript. SN, DD, SP, SNa,

REFERENCES
17.

1. Muller V, de Boer RJ, Bonhoeffer S, Szathmary E. An evolutionary perspective
on the systems of adaptive immunity. Biol Rev Camb Philos Soc. (2018)
93:505–28. doi: 10.1111/brv.12355
2. Medzhitov R, Janeway C Jr. Innate immune recognition:
mechanisms and pathways. Immunol Rev. (2000) 173:89–
97. doi: 10.1034/j.1600-065X.2000.917309.x
3. Netea MG, Quintin J, van der Meer JW. Trained immunity:
a memory for innate host defense. Cell Host Microbe. (2011)
9:355–61. doi: 10.1016/j.chom.2011.04.006
4. Netea MG. Training innate immunity: the changing concept of
immunological memory in innate host defence. Eur J Clin Invest. (2013)
43:881–4. doi: 10.1111/eci.12132
5. Kurtz J, Franz K. Innate defence: evidence for memory in invertebrate
immunity. Nature. (2003) 425:37–8. doi: 10.1038/425037a
6. De Santa F, Totaro MG, Prosperini E, Notarbartolo S, Testa G, Natoli
G. The histone H3 lysine-27 demethylase Jmjd3 links inflammation to
inhibition of polycomb-mediated gene silencing. Cell. (2007) 130:1083–
94. doi: 10.1016/j.cell.2007.08.019
7. Saeed S, Quintin J, Kerstens HH, Rao NA, Aghajanirefah A, Matarese
F, et al. Epigenetic programming of monocyte-to-macrophage
differentiation and trained innate immunity. Science. (2014)
345:1251086. doi: 10.1126/science.1251086
8. Hamada A, Torre C, Drancourt M, Ghigo E. Trained
immunity carried by non-immune cells. Front Microbiol. (2018)
9:3225. doi: 10.3389/fmicb.2018.03225
9. Kaufmann E, Sanz J, Dunn JL, Khan N, Mendonca LE, Pacis
A, et al. BCG educates hematopoietic stem cells to generate
protective innate immunity against tuberculosis. Cell. (2018)
172:176–90.e19. doi: 10.1016/j.cell.2017.12.031
10. Kumar H, Kawai T, Akira S. Pathogen recognition by the
innate immune system. Int Rev Immunol. (2011) 30:16–
34. doi: 10.3109/08830185.2010.529976
11. Pahari S, Kaur G, Negi S, Aqdas M, Das DK, Bashir H, et al. Reinforcing
the functionality of mononuclear phagocyte system to control tuberculosis.
Front Immunol. (2018) 9:193. doi: 10.3389/fimmu.2018.00193
12. Pahari S, Negi S, Aqdas M, Arnett E, Schlesinger LS, Agrewala JN. Induction
of autophagy through CLEC4E in combination with TLR4: an innovative
strategy to restrict the survival of Mycobacterium tuberculosis. Autophagy.
(2019) 8:1–23. doi: 10.1080/15548627.2019.1658436
13. Negi S, Pahari S, Das DK, Khan N, Agrewala JN. Curdlan limits
mycobacterium tuberculosis survival through STAT-1 regulated nitric oxide
production. Front Microbiol. (2019) 10:1173. doi: 10.3389/fmicb.2019.01173
14. Rakoff-Nahoum S, Paglino J, Eslami-Varzaneh F, Edberg S,
Medzhitov R. Recognition of commensal microflora by tolllike receptors is required for intestinal homeostasis. Cell. (2004)
118:229–41. doi: 10.1016/j.cell.2004.07.002
15. Gewirtz AT, Simon PO Jr, Schmitt CK, Taylor LJ, Hagedorn CH, O’Brien
AD, et al. Salmonella typhimurium translocates flagellin across intestinal
epithelia, inducing a proinflammatory response. J Clin Invest. (2001) 107:99–
109. doi: 10.1172/JCI10501
16. Gewirtz AT, Navas TA, Lyons S, Godowski PJ, Madara JL. Cutting
edge: bacterial flagellin activates basolaterally expressed TLR5 to induce

Frontiers in Immunology | www.frontiersin.org

18.

19.

20.

21.

22.

23.

24.

25.

26.

27.

28.

29.

30.

31.
32.

8

epithelial proinflammatory gene expression. J Immunol. (2001) 167:1882–
5. doi: 10.4049/jimmunol.167.4.1882
Mills KH. TLR-dependent T cell activation in autoimmunity. Nat Rev
Immunol. (2011) 11:807–22. doi: 10.1038/nri3095
Kleinnijenhuis J, Quintin J, Preijers F, Joosten LA, Ifrim DC, Saeed S, et al.
Bacille Calmette-Guerin induces NOD2-dependent nonspecific protection
from reinfection via epigenetic reprogramming of monocytes. Proc Natl
Acad Sci USA. (2012) 109:17537–42. doi: 10.1073/pnas.1202870109
Kleinnijenhuis J, Quintin J, Preijers F, Joosten LA, Jacobs C,
Xavier R, et al. BCG-induced trained immunity in NK cells: Role
for non-specific protection to infection. Clin Immunol. (2014)
155:213–9. doi: 10.1016/j.clim.2014.10.005
Kleinnijenhuis J, Quintin J, Preijers F, Benn CS, Joosten LA, Jacobs C, et
al. Long-lasting effects of BCG vaccination on both heterologous Th1/Th17
responses and innate trained immunity. J Innate Immun. (2014) 6:152–
8. doi: 10.1159/000355628
Benn CS, Netea MG, Selin LK, Aaby P. A small jab - a big effect:
nonspecific immunomodulation by vaccines. Trends Immunol. (2013)
34:431–9. doi: 10.1016/j.it.2013.04.004
Negi S, Pahari S, Bashir H, Agrewala JN. Gut microbiota regulates mincle
mediated activation of lung dendritic cells to protect against Mycobacterium
tuberculosis. Front Immunol. (2019) 10:1142. doi: 10.3389/fimmu.2019.01142
Ley RE, Hamady M, Lozupone C, Turnbaugh PJ, Ramey RR, Bircher JS, et al.
Evolution of mammals and their gut microbes. Science. (2008) 320:1647–
51. doi: 10.1126/science.1155725
Slack E, Hapfelmeier S, Stecher B, Velykoredko Y, Stoel M,
Lawson MA, et al. Innate and adaptive immunity cooperate
flexibly to maintain host-microbiota mutualism. Science. (2009)
325:617–20. doi: 10.1126/science.1172747
Bron PA, van Baarlen P, Kleerebezem M. Emerging molecular insights into
the interaction between probiotics and the host intestinal mucosa. Nat Rev
Microbiol. (2011) 10:66–78. doi: 10.1038/nrmicro2690
Moens E, Veldhoen M. Epithelial barrier biology: good
fences make good neighbours. Immunology. (2012) 135:1–
8. doi: 10.1111/j.1365-2567.2011.03506.x
Kamada N, Seo SU, Chen GY, Nunez G. Role of the gut microbiota in
immunity and inflammatory disease. Nat Rev Immunol. (2013) 13:321–
35. doi: 10.1038/nri3430
Khan N, Vidyarthi A, Nadeem S, Negi S, Nair G, Agrewala JN. Alteration in
the gut microbiota provokes susceptibility to tuberculosis. Front Immunol.
(2016) 7:529. doi: 10.3389/fimmu.2016.00529
Round JL, Mazmanian SK. The gut microbiota shapes intestinal immune
responses during health and disease. Nat Rev Immunol. (2009) 9:313–
23. doi: 10.1038/nri2515
Maynard CL, Elson CO, Hatton RD, Weaver CT. Reciprocal interactions
of the intestinal microbiota and immune system. Nature. (2012) 489:231–
41. doi: 10.1038/nature11551
Klijn A, Mercenier A, Arigoni F. Lessons from the genomes of bifidobacteria.
FEMS Microbiol Rev. (2005) 29:491–509. doi: 10.1016/j.fmrre.2005.04.010
Carvalho FA, Barnich N, Sivignon A, Darcha C, Chan CH, Stanners
CP, et al. Crohn’s disease adherent-invasive Escherichia coli colonize
and induce strong gut inflammation in transgenic mice expressing
human CEACAM. J Exp Med. (2009) 206:2179–89. doi: 10.1084/jem.20
090741

October 2019 | Volume 10 | Article 2441

Negi et al.

Microbiota in Generation of Innate Memory

54. Jia W, Xie G, Jia W. Bile acid-microbiota crosstalk in gastrointestinal
inflammation and carcinogenesis. Nat Rev Gastroenterol Hepatol. (2018)
15:111–28. doi: 10.1038/nrgastro.2017.119
55. Ridlon JM, Kang DJ, Hylemon PB. Bile salt biotransformations
by human intestinal bacteria. J Lipid Res. (2006) 47:241–
59. doi: 10.1194/jlr.R500013-JLR200
56. Wang G, Huang S, Wang Y, Cai S, Yu H, Liu H, et al. Bridging intestinal
immunity and gut microbiota by metabolites. Cell Mol Life Sci. (2019)
76:3917–37. doi: 10.1007/s00018-019-03190-6
57. Singh N, Thangaraju M, Prasad PD, Martin PM, Lambert NA, Boettger
T, et al. Blockade of dendritic cell development by bacterial fermentation
products butyrate and propionate through a transporter (Slc5a8)-dependent
inhibition of histone deacetylases. J Biol Chem. (2010) 285:27601–
8. doi: 10.1074/jbc.M110.102947
58. Chang PV, Hao L, Offermanns S, Medzhitov R. The microbial
metabolite butyrate regulates intestinal macrophage function via
histone deacetylase inhibition. Proc Natl Acad Sci USA. (2014)
111:2247–52. doi: 10.1073/pnas.1322269111
59. Trompette A, Gollwitzer ES, Yadava K, Sichelstiel AK, Sprenger N, NgomBru C, et al. Gut microbiota metabolism of dietary fiber influences
allergic airway disease and hematopoiesis. Nat Med. (2014) 20:159–
66. doi: 10.1038/nm.3444
60. Balmer ML, Schurch CM, Saito Y, Geuking MB, Li H, Cuenca
M, et al. Microbiota-derived compounds drive steady-state
granulopoiesis via MyD88/TICAM signaling. J Immunol. (2014)
193:5273–83. doi: 10.4049/jimmunol.1400762
61. Khosravi A, Yanez A, Price JG, Chow A, Merad M, Goodridge HS, et al. Gut
microbiota promote hematopoiesis to control bacterial infection. Cell Host
Microbe. (2014) 15:374–81. doi: 10.1016/j.chom.2014.02.006
62. Wang H, Chen J, Hollister K, Sowers LC, Forman BM. Endogenous bile
acids are ligands for the nuclear receptor FXR/BAR. Mol Cell. (1999) 3:543–
53. doi: 10.1016/S1097-2765(00)80348-2
63. Wang YD, Chen WD, Yu D, Forman BM, Huang W. The G-proteincoupled bile acid receptor, Gpbar1 (TGR5), negatively regulates hepatic
inflammatory response through antagonizing nuclear factor κ light-chain
enhancer of activated B cells (NF-κB) in mice. Hepatology. (2011) 54:1421–
32. doi: 10.1002/hep.24525
64. Vavassori P, Mencarelli A, Renga B, Distrutti E, Fiorucci S. The bile acid
receptor FXR is a modulator of intestinal innate immunity. J Immunol.
(2009) 183:6251–61. doi: 10.4049/jimmunol.0803978
65. Christ A, Gunther P, Lauterbach MAR, Duewell P, Biswas D, Pelka
K, et al. Western Diet Triggers NLRP3-Dependent Innate Immune
Reprogramming. Cell. (2018) 172:162–75.e14. doi: 10.1016/j.cell.2017.
12.013
66. Chu DM, Antony KM, Ma J, Prince AL, Showalter L, et al. The early infant
gut microbiome varies in association with a maternal high-fat diet. Genome
Med. (2016) 8:77. doi: 10.1186/s13073-016-0330-z
67. Myles IA, Fontecilla NM, Janelsins BM, Vithayathil PJ, Segre JA, Datta SK.
Parental dietary fat intake alters offspring microbiome and immunity. J
Immunol. (2013) 191:3200–9. doi: 10.4049/jimmunol.1301057
68. Rodriguez JM. The origin of human milk bacteria: is there a bacterial enteromammary pathway during late pregnancy and lactation? Adv Nutr. (2014)
5:779–84. doi: 10.3945/an.114.007229
69. Latuga MS, Stuebe A, Seed PC. A review of the source and
function of microbiota in breast milk. Semin Reprod Med. (2014)
32:68–73. doi: 10.1055/s-0033-1361824
70. Gomez de Aguero M, Ganal-Vonarburg SC, Fuhrer T, Rupp S, Uchimura
Y, Li H, et al. The maternal microbiota drives early postnatal innate
immune development. Science. (2016) 351:1296–302. doi: 10.1126/science.
aad2571
71. Tang B, Jia H, Kast RJ. Thomas EA. Epigenetic changes at gene promoters
in response to immune activation in utero. Brain Behav Immun. (2013)
30:168–75. doi: 10.1016/j.bbi.2013.01.086
72. Choi GB, Yim YS, Wong H, Kim S, Kim H, Kim SV, et al. The maternal
interleukin-17a pathway in mice promotes autism-like phenotypes in
offspring. Science. (2016) 351:933–9. doi: 10.1126/science.aad0314
73. Ramirez K, Shea DT, McKim DB, Reader BF, Sheridan JF.
Imipramine attenuates neuroinflammatory signaling and reverses

33. Kuhn KA, Stappenbeck TS. Peripheral education of the immune
system by the colonic microbiota. Semin Immunol. (2013)
25:364–9. doi: 10.1016/j.smim.2013.10.002
34. Round JL, Mazmanian SK. Inducible Foxp3+ regulatory T-cell development
by a commensal bacterium of the intestinal microbiota. Proc Natl Acad Sci
USA. (2010) 107:12204–9. doi: 10.1073/pnas.0909122107
35. Ivanov II, Atarashi K, Manel N, Brodie EL, Shima T, Karaoz U, et al.
Induction of intestinal Th17 cells by segmented filamentous bacteria. Cell.
(2009) 139:485–98. doi: 10.1016/j.cell.2009.09.033
36. Gorjifard S, Goldszmid RS. Microbiota-myeloid cell crosstalk beyond the
gut. J Leukoc Biol. (2016) 100:865–79. doi: 10.1189/jlb.3RI0516-222R
37. Weaver LK, Minichino D, Biswas C, Chu N, Lee JJ, Bittinger
K,
et
al.
Microbiota-dependent
signals
are
required
to
sustain TLR-mediated immune responses. JCI Insight. (2019)
4:124370. doi: 10.1172/jci.insight.124370
38. McCoy KD, Burkhard R, Geuking MB. The microbiome
and immune memory formation. Immunol Cell Biol. (2019)
97:625–35. doi: 10.1111/imcb.12273
39. Gourbal B, Pinaud S, Beckers GJM, Van Der Meer JWM, Conrath U, Netea
MG. Innate immune memory: an evolutionary perspective. Immunol Rev.
(2018) 283:21–40. doi: 10.1111/imr.12647
40. Mitroulis I, Ruppova K, Wang B, Chen LS, Grzybek M, Grinenko T,
et al. Modulation of myelopoiesis progenitors is an integral component
of trained immunity. Cell. (2018) 172:147–61.e12. doi: 10.1016/j.cell.2017.
11.034
41. Quintin J, Saeed S, Martens JHA, Giamarellos-Bourboulis EJ, Ifrim DC, Logie
C, et al. Candida albicans infection affords protection against reinfection
via functional reprogramming of monocytes. Cell Host Microbe. (2012)
12:223–32. doi: 10.1016/j.chom.2012.06.006
42. Pahari S, Kaur G, Aqdas M, Negi S, Chatterjee D, Bashir H, et
al. Bolstering immunity through pattern recognition receptors: a
unique approach to control tuberculosis. Front Immunol. (2017)
8:906. doi: 10.3389/fimmu.2017.00906
43. Ribes S, Meister T, Ott M, Redlich S, Janova H, Hanisch UK, et
al. Intraperitoneal prophylaxis with CpG oligodeoxynucleotides protects
neutropenic mice against intracerebral Escherichia coli K1 infection. J
Neuroinflammation. (2014) 11:14. doi: 10.1186/1742-2094-11-14
44. Marakalala MJ, Williams DL, Hoving JC, Engstad R, Netea MG,
Brown GD. Dectin-1 plays a redundant role in the immunomodulatory
activities of β-glucan-rich ligands in vivo. Microbes Infect. (2013) 15:511–
5. doi: 10.1016/j.micinf.2013.03.002
45. Di Luzio NR, Williams DL. Protective effect of glucan against systemic
Staphylococcus aureus septicemia in normal and leukemic mice. Infect
Immun. (1978) 20:804–10.
46. Krahenbuhl JL, Sharma SD, Ferraresi RW, Remington JS. Effects of muramyl
dipeptide treatment on resistance to infection with Toxoplasma gondii in
mice. Infect Immun. (1981) 31:716–22.
47. Romee R, Rosario M, Berrien-Elliott MM, Wagner JA, Jewell BA,
Schappe T, et al. Cytokine-induced memory-like natural killer cells exhibit
enhanced responses against myeloid leukemia. Sci Transl Med. (2016)
8:357ra123. doi: 10.1126/scitranslmed.aaf2341
48. Romee R, Schneider SE, Leong JW, Chase JM, Keppel CR, Sullivan RP, et
al. Cytokine activation induces human memory-like NK cells. Blood. (2012)
120:4751–60. doi: 10.1182/blood-2012-04-419283
49. Hole CR, Wager CML, Castro-Lopez N, Campuzano A, Cai H, Wozniak
KL, et al. Induction of memory-like dendritic cell responses in vivo. Nat
Commun. (2019) 10:2955. doi: 10.1038/s41467-019-10486-5
50. Rooks MG, Garrett WS. Gut microbiota, metabolites and host immunity. Nat
Rev Immunol. (2016) 16:341–52. doi: 10.1038/nri.2016.42
51. Levy M, Thaiss CA, Elinav E. Metabolites: messengers between the
microbiota and the immune system. Genes Dev. (2016) 30:1589–
97. doi: 10.1101/gad.284091.116
52. Tremaroli V, Backhed F. Functional interactions between the gut microbiota
and host metabolism. Nature. (2012) 489:242–9. doi: 10.1038/nature11552
53. Kitahara M, Takamine F, Imamura T, Benno Y. Clostridium hiranonis
sp. nov., a human intestinal bacterium with bile acid 7alphadehydroxylating activity. Int J Syst Evol Microbiol. (2001) 51(Pt
1):39–44. doi: 10.1099/00207713-51-1-39

Frontiers in Immunology | www.frontiersin.org

9

October 2019 | Volume 10 | Article 2441

Negi et al.

74.

75.

76.

77.

78.

79.

80.

81.

82.

83.

84.

85.

86.

87.

88.

89.

90.

91.

92.

Microbiota in Generation of Innate Memory

stress-induced social avoidance. Brain Behav Immun. (2015)
46:212–20. doi: 10.1016/j.bbi.2015.01.016
Salam AP, Borsini A, Zunszain PA. Trained innate immunity: a salient factor
in the pathogenesis of neuroimmune psychiatric disorders. Mol Psychiatry.
(2018) 23:170–6. doi: 10.1038/mp.2017.186
Seong SY, Matzinger P. Hydrophobicity: an ancient damage-associated
molecular pattern that initiates innate immune responses. Nat Rev Immunol.
(2004) 4:469–78. doi: 10.1038/nri1372
Fleshner M. Stress-evoked sterile inflammation, danger associated
molecular patterns (DAMPs), microbial associated molecular patterns
(MAMPs) and the inflammasome. Brain Behav Immun. (2013)
27:1–7. doi: 10.1016/j.bbi.2012.08.012
Maekawa T, Kim S, Nakai D, Makino C, Takagi T, Ogura H, et
al. Social isolation stress induces ATF-7 phosphorylation and impairs
silencing of the 5-HT 5B receptor gene. EMBO J. (2010) 29:196–
208. doi: 10.1038/emboj.2009.318
Ganal SC, Sanos SL, Kallfass C, Oberle K, Johner C, Kirschning C, et
al. Priming of natural killer cells by nonmucosal mononuclear phagocytes
requires instructive signals from commensal microbiota. Immunity. (2012)
37:171–86. doi: 10.1016/j.immuni.2012.05.020
Rodrigues J, Brayner FA, Alves LC, Dixit R, Barillas-Mury C. Hemocyte
differentiation mediates innate immune memory in Anopheles
gambiae mosquitoes. Science. (2010) 329:1353–5. doi: 10.1126/science.
1190689
Mulder WJM, Ochando J, Joosten LAB, Fayad ZA, Netea MG. Therapeutic
targeting of trained immunity. Nat Rev Drug Discov. (2019) 18:553–
66. doi: 10.1038/s41573-019-0025-4
Smale ST, Tarakhovsky A, Natoli G. Chromatin contributions to the
regulation of innate immunity. Annu Rev Immunol. (2014) 32:489–
511. doi: 10.1146/annurev-immunol-031210-101303
Ghisletti S, Barozzi I, Mietton F, Polletti S, De Santa F, Venturini E,
et al. Identification and characterization of enhancers controlling the
inflammatory gene expression program in macrophages. Immunity. (2010)
32:317–28. doi: 10.1016/j.immuni.2010.02.008
Smale ST, Natoli G. Transcriptional control of inflammatory
responses.
Cold
Spring
Harb
Perspect
Biol.
(2014)
6:a016261. doi: 10.1101/cshperspect.a016261
Barozzi I, Simonatto M, Bonifacio S, Yang L, Rohs R, Ghisletti S, et al.
Coregulation of transcription factor binding and nucleosome occupancy
through DNA features of mammalian enhancers. Mol Cell. (2014) 54:844–
57. doi: 10.1016/j.molcel.2014.04.006
Yoshida K, Maekawa T, Zhu Y, Renard-Guillet C, Chatton B, Inoue K,
et al. The transcription factor ATF7 mediates lipopolysaccharide-induced
epigenetic changes in macrophages involved in innate immunological
memory. Nat Immunol. (2015) 16:1034–43. doi: 10.1038/ni.3257
Ifrim DC, Quintin J, Joosten LA, Jacobs C, Jansen T, Jacobs L, et al. Trained
immunity or tolerance: opposing functional programs induced in human
monocytes after engagement of various pattern recognition receptors. Clin
Vaccine Immunol. (2014) 21:534–45. doi: 10.1128/CVI.00688-13
Ostuni R, Piccolo V, Barozzi I, Polletti S, Termanini A, Bonifacio S, et al.
Latent enhancers activated by stimulation in differentiated cells. Cell. (2013)
152:157–71. doi: 10.1016/j.cell.2012.12.018
Yanez A, Hassanzadeh-Kiabi N, Ng MY, Megias J, Subramanian A, Liu GY,
et al. Detection of a TLR2 agonist by hematopoietic stem and progenitor
cells impacts the function of the macrophages they produce. Eur J Immunol.
(2013) 43:2114–25. doi: 10.1002/eji.201343403
Arts RJ, Joosten LA, Netea MG. Immunometabolic circuits
in
trained
immunity.
Semin
Immunol.
(2016)
28:425–
30. doi: 10.1016/j.smim.2016.09.002
Dominguez-Andres J, Joosten LA, Netea MG. Induction of innate immune
memory: the role of cellular metabolism. Curr Opin Immunol. (2019) 56:10–
6. doi: 10.1016/j.coi.2018.09.001
Cheng SC, Quintin J, Cramer RA, Shepardson KM, Saeed S,
Kumar V, et al. mTOR- and HIF-1α-mediated aerobic glycolysis
as metabolic basis for trained immunity. Science. (2014)
345:1250684. doi: 10.1126/science.1250684
Arts RJ, Novakovic B, Ter Horst R, Carvalho A, Bekkering S,
Lachmandas E, et al. Glutaminolysis and fumarate accumulation integrate

Frontiers in Immunology | www.frontiersin.org

93.

94.

95.

96.
97.
98.

99.

100.

101.

102.

103.

104.
105.

106.

107.

108.

109.
110.

111.

112.

10

immunometabolic and epigenetic programs in trained immunity. Cell
Metab. (2016) 24:807–19. doi: 10.1016/j.cmet.2016.10.008
Bekkering S, Arts RJW, Novakovic B, Kourtzelis I, van der Heijden
C, Li Y, et al. Metabolic Induction of Trained Immunity through the
Mevalonate Pathway. Cell. (2018) 172:135–46.e9. doi: 10.1016/j.cell.2017.
11.025
Benit P, Letouze E, Rak M, Aubry L, Burnichon N, Favier J, et al.
Unsuspected task for an old team: succinate, fumarate and other Krebs cycle
acids in metabolic remodeling. Biochim Biophys Acta. (2014) 1837:1330–
7. doi: 10.1016/j.bbabio.2014.03.013
Wendeln AC, Degenhardt K, Kaurani L, Gertig M, Ulas T, Jain G, et al. Innate
immune memory in the brain shapes neurological disease hallmarks. Nature.
(2018) 556:332–8. doi: 10.1038/s41586-018-0023-4
McGuckin MA, Linden SK, Sutton P, Florin TH. Mucin dynamics and enteric
pathogens. Nat Rev Microbiol. (2011) 9:265–78. doi: 10.1038/nrmicro2538
Ganz T. Defensins: antimicrobial peptides of innate immunity. Nat Rev
Immunol. (2003) 3:710–20. doi: 10.1038/nri1180
Cash HL, Whitham CV, Behrendt CL, Hooper LV. Symbiotic bacteria direct
expression of an intestinal bactericidal lectin. Science. (2006) 313:1126–
30. doi: 10.1126/science.1127119
Mestecky J, Russell MW. Specific antibody activity, glycan heterogeneity
and polyreactivity contribute to the protective activity of S-IgA at mucosal
surfaces. Immunol Lett. (2009) 124:57–62. doi: 10.1016/j.imlet.2009.03.013
Castellaneta A, Sumpter TL, Chen L, Tokita D, Thomson AW. NOD2
ligation subverts IFN-α production by liver plasmacytoid dendritic cells
and inhibits their T cell allostimulatory activity via B7-H1 up-regulation. J
Immunol. (2009) 183:6922–32. doi: 10.4049/jimmunol.0900582
Mueller T, Terada T, Rosenberg IM, Shibolet O, Podolsky DK. Th2 cytokines
down-regulate TLR expression and function in human intestinal epithelial
cells. J Immunol. (2006) 176:5805–14. doi: 10.4049/jimmunol.176.10.5805
Carvalho FA, Aitken JD, Gewirtz AT, Vijay-Kumar M. TLR5 activation
induces secretory interleukin-1 receptor antagonist (sIL-1Ra) and reduces
inflammasome-associated tissue damage. Mucosal Immunol. (2011) 4:102–
11. doi: 10.1038/mi.2010.57
Cario E, Podolsky DK. Differential alteration in intestinal
epithelial cell expression of toll-like receptor 3 (TLR3) and
TLR4 in inflammatory bowel disease. Infect Immun. (2000)
68:7010–7. doi: 10.1128/IAI.68.12.7010-7017.2000
Wells JM. Immunomodulatory mechanisms of lactobacilli. Microb Cell Fact.
(2011) 10(Suppl. 1):S17. doi: 10.1186/1475-2859-10-S1-S17
Santecchia I, Vernel-Pauillac F, Rasid O, Quintin J, Gomes-Solecki M, Boneca
IG, et al. Innate immune memory through TLR2 and NOD2 contributes
to the control of Leptospira interrogans infection. PLoS Pathog. (2019)
15:e1007811. doi: 10.1371/journal.ppat.1007811
Yao Y, Jeyanathan M, Haddadi S, Barra NG, Vaseghi-Shanjani M,
Damjanovic D, et al. Induction of autonomous memory alveolar
macrophages requires T cell help and is critical to trained immunity.
Cell. (2018) 175:1634–50.e17. doi: 10.1016/j.cell.2018.09.042
Jackson EM, Herbst-Kralovetz MM. Intranasal vaccination with murabutide
enhances humoral and mucosal immune responses to a virus-like particle
vaccine. PLoS ONE. (2012) 7:e41529. doi: 10.1371/journal.pone.0041529
Honko AN, Sriranganathan N, Lees CJ, Mizel SB. Flagellin is
an effective adjuvant for immunization against lethal respiratory
challenge with Yersinia pestis. Infect Immun. (2006) 74:1113–
20. doi: 10.1128/IAI.74.2.1113-1120.2006
Silhavy TJ, Kahne D, Walker S. The bacterial cell envelope. Cold Spring Harb
Perspect Biol. (2010) 2:a000414. doi: 10.1101/cshperspect.a000414
Irazoki O, Hernandez SB, Cava F. Peptidoglycan muropeptides: release,
perception, and functions as signaling molecules. Front Microbiol. (2019)
10:500. doi: 10.3389/fmicb.2019.00500
Miao EA, Alpuche-Aranda CM, Dors M, Clark AE, Bader MW, Miller SI,
et al. Cytoplasmic flagellin activates caspase-1 and secretion of interleukin
1beta via Ipaf. Nat Immunol. (2006) 7:569–75. doi: 10.1038/ni1344
Levy M, Thaiss CA, Zeevi D, Dohnalova L, Zilberman-Schapira
G, Mahdi JA, et al. Microbiota-modulated metabolites shape the
intestinal microenvironment by regulating NLRP6 inflammasome
signaling.
Cell.
(2015)
163:1428–43.
doi:
10.1016/j.cell.2015.
10.048

October 2019 | Volume 10 | Article 2441

Negi et al.

Microbiota in Generation of Innate Memory

133. Sahoo M, Ceballos-Olvera I, del Barrio L, Re F. Role of the inflammasome,
IL-1β, and IL-18 in bacterial infections. ScientificWorldJournal. (2011)
11:2037–50. doi: 10.1100/2011/212680
134. Clarke TB, Davis KM, Lysenko ES, Zhou AY, Yu Y, Weiser JN. Recognition
of peptidoglycan from the microbiota by Nod1 enhances systemic innate
immunity. Nat Med. (2010) 16:228–31. doi: 10.1038/nm.2087
135. Finlay CM, Stefanska AM, Walsh KP, Kelly PJ, Boon L, Lavelle EC, et al.
Helminth products protect against autoimmunity via innate type 2 cytokines
IL-5 and IL-33, which promote eosinophilia. J Immunol. (2016) 196:703–
14. doi: 10.4049/jimmunol.1501820
136. Soehnlein O, Lindbom L. Phagocyte partnership during the onset
and resolution of inflammation. Nat Rev Immunol. (2010) 10:427–
39. doi: 10.1038/nri2779
137. MacVittie TJ, Walker RI. Canine granulopoiesis: alterations induced by
suppression of gram-negative flora. Exp Hematol. (1978) 6:639–47.
138. Chang CF, Pollard M. Effects of microbial flora on levels of colonay
stimulating factor in serums of irradiated CFW mice. Proc Soc Exp Biol Med.
(1973) 144:177–80. doi: 10.3181/00379727-144-37551
139. Joshi JH, Entringer MA, Robinson WA. Bacterial stimulation of serum
colony-stimulating activity and neutrophil production in germ-free mice.
Proc Soc Exp Biol Med. (1979) 162:44–7. doi: 10.3181/00379727-162-40615
140. Staber FG, Tarcsay L, Dukor P. Modulations of myelopoiesis in vivo by
chemically pure preparations of cell wall components from gram-negative
bacteria: effects at different stages. Infect Immun. (1978) 20:40–9.
141. Goris H, de Boer F, van der Waaij D. Myelopoiesis in experimentally
contaminated specific-pathogen-free and germfree mice during oral
administration of polymyxin. Infect Immun. (1985) 50:437–41
142. Nicaise P, Gleizes A, Sandre C, Forestier F, Kergot R, Quero AM,
et al. Influence of intestinal microflora on murine bone marrow
and spleen macrophage precursors. Scand J Immunol. (1998) 48:585–
91. doi: 10.1046/j.1365-3083.1998.00487.x
143. Burgess SL, Buonomo E, Carey M, Cowardin C, Naylor C, Noor Z, et al.
Bone marrow dendritic cells from mice with an altered microbiota provide
interleukin 17A-dependent protection against Entamoeba histolytica colitis.
MBio. (2014) 5:e01817. doi: 10.1128/mBio.01817-14
144. Walachowski S, Tabouret G, Fabre M, Foucras G. Molecular analysis of a
short-term model of β-glucans-trained immunity highlights the accessory
contribution of GM-CSF in priming mouse macrophages response. Front
Immunol. (2017) 8:1089. doi: 10.3389/fimmu.2017.01089
145. Schulz C, Gomez Perdiguero E, Chorro L, Szabo-Rogers H,
Cagnard N, Kierdorf K, et al. A lineage of myeloid cells
independent of Myb and hematopoietic stem cells. Science. (2012)
336:86–90. doi: 10.1126/science.1219179
146. Hoeffel G, Ginhoux F. Ontogeny of tissue-resident macrophages. Front
Immunol. (2015) 6:486. doi: 10.3389/fimmu.2015.00486
147. Sieweke MH, Allen JE. Beyond stem cells: self-renewal of differentiated
macrophages. Science. (2013) 342:1242974. doi: 10.1126/science.1242974
148. Hergott CB, Roche AM, Tamashiro E, Clarke TB, Bailey AG,
Laughlin A, et al. Peptidoglycan from the gut microbiota governs
the lifespan of circulating phagocytes at homeostasis. Blood. (2016)
127:2460–71. doi: 10.1182/blood-2015-10-675173
149. Spits H, Artis D, Colonna M, Diefenbach A, Di Santo JP, Eberl G, et al. Innate
lymphoid cells–a proposal for uniform nomenclature. Nat Rev Immunol.
(2013) 13:145–9. doi: 10.1038/nri3365
150. Zheng Y, Valdez PA, Danilenko DM, Hu Y, Sa SM, Gong Q, et al. Interleukin22 mediates early host defense against attaching and effacing bacterial
pathogens. Nat Med. (2008) 14:282–9. doi: 10.1038/nm1720
151. Pickert G, Neufert C, Leppkes M, Zheng Y, Wittkopf N, Warntjen M, et al.
STAT3 links IL-22 signaling in intestinal epithelial cells to mucosal wound
healing. J Exp Med. (2009) 206:1465–72. doi: 10.1084/jem.20082683
152. Sonnenberg GF, Monticelli LA, Elloso MM, Fouser LA, Artis D.
CD4(+) lymphoid tissue-inducer cells promote innate immunity
in the gut. Immunity. (2011) 34:122–34. doi: 10.1016/j.immuni.2010.
12.009
153. Lee JS, Cella M, McDonald KG, Garlanda C, Kennedy GD, Nukaya M, et
al. AHR drives the development of gut ILC22 cells and postnatal lymphoid
tissues via pathways dependent on and independent of Notch. Nat Immunol.
(2011) 13:144–51. doi: 10.1038/ni.2187

113. Hajam IA, Dar PA, Shahnawaz I, Jaume JC, Lee JH. Bacterial
flagellin-a potent immunomodulatory agent. Exp Mol Med. (2017)
49:e373. doi: 10.1038/emm.2017.172
114. Kinnebrew MA, Buffie CG, Diehl GE, Zenewicz LA, Leiner I, Hohl TM, et al.
Interleukin 23 production by intestinal CD103(+)CD11b(+) dendritic cells
in response to bacterial flagellin enhances mucosal innate immune defense.
Immunity. (2012) 36:276–87. doi: 10.1016/j.immuni.2011.12.011
115. Garcia-Valtanen P, Guzman-Genuino RM, Williams DL, Hayball JD, Diener
KR. Evaluation of trained immunity by β-1, 3 (d)-glucan on murine
monocytes in vitro and duration of response in vivo. Immunol Cell Biol.
(2017) 95:601–10. doi: 10.1038/icb.2017.13
116. Schorey JS, Lawrence C. The pattern recognition receptor Dectin1: from fungi to mycobacteria. Curr Drug Targets. (2008) 9:123–
9. doi: 10.2174/138945008783502430
117. Chow JC, Young DW, Golenbock DT, Christ WJ, Gusovsky F. Toll-like
receptor-4 mediates lipopolysaccharide-induced signal transduction. J Biol
Chem. (1999) 274:10689–92. doi: 10.1074/jbc.274.16.10689
118. Williams AE, Edwards L, Humphreys IR, Snelgrove R, Rae A, Rappuoli
R, et al. Innate imprinting by the modified heat-labile toxin of Escherichia
coli (LTK63) provides generic protection against lung infectious disease. J
Immunol. (2004) 173:7435–43. doi: 10.4049/jimmunol.173.12.7435
119. Breyne K, Steenbrugge J, Demeyere K, Vanden Berghe T, Meyer E.
Preconditioning with lipopolysaccharide or lipoteichoic acid protects against
Staphylococcus aureus mammary infection in mice. Front Immunol. (2017)
8:833. doi: 10.3389/fimmu.2017.00833
120. Eckburg PB, Bik EM, Bernstein CN, Purdom E, Dethlefsen L, Sargent M,
et al. Diversity of the human intestinal microbial flora. Science. (2005)
308:1635–8. doi: 10.1126/science.1110591
121. Frosali S, Pagliari D, Gambassi G, Landolfi R, Pandolfi F, Cianci R. How
the intricate interaction among toll-like receptors, microbiota, and intestinal
immunity can influence gastrointestinal pathology. J Immunol Res. (2015)
2015:489821. doi: 10.1155/2015/489821
122. Vijay-Kumar M, Wu H, Aitken J, Kolachala VL, Neish AS, Sitaraman SV,
et al. Activation of toll-like receptor 3 protects against DSS-induced acute
colitis. Inflamm Bowel Dis. (2007) 13:856–64. doi: 10.1002/ibd.20142
123. Kawashima T, Kosaka A, Yan H, Guo Z, Uchiyama R, Fukui R, et al.
Double-stranded RNA of intestinal commensal but not pathogenic bacteria
triggers production of protective interferon-β. Immunity. (2013) 38:1187–
97. doi: 10.1016/j.immuni.2013.02.024
124. Furuta T, Kikuchi T, Akira S, Watanabe N, Yoshikawa Y. Roles of the small
intestine for induction of toll-like receptor 4-mediated innate resistance in
naturally acquired murine toxoplasmosis. Int Immunol. (2006) 18:1655–
62. doi: 10.1093/intimm/dxl099
125. Hayashi F, Smith KD, Ozinsky A, Hawn TR, Yi EC, Goodlett DR, et al.
The innate immune response to bacterial flagellin is mediated by Toll-like
receptor 5. Nature. (2001) 410:1099–103. doi: 10.1038/35074106
126. Uematsu S, Jang MH, Chevrier N, Guo Z, Kumagai Y, Yamamoto M,
et al. Detection of pathogenic intestinal bacteria by Toll-like receptor 5
on intestinal CD11c+ lamina propria cells. Nat Immunol. (2006) 7:868–
74. doi: 10.1038/ni1362
127. Vilaysane A, Muruve DA. The innate immune response to DNA. Semin
Immunol. (2009) 21:208–14. doi: 10.1016/j.smim.2009.05.006
128. Gribar SC, Sodhi CP, Richardson WM, Anand RJ, Gittes GK, Branca
MF, et al. Reciprocal expression and signaling of TLR4 and TLR9 in the
pathogenesis and treatment of necrotizing enterocolitis. J Immunol. (2009)
182:636–46. doi: 10.4049/jimmunol.182.1.636
129. Lee J, Mo JH, Katakura K, Alkalay I, Rucker AN, Liu YT, et al. Maintenance
of colonic homeostasis by distinctive apical TLR9 signalling in intestinal
epithelial cells. Nat Cell Biol. (2006) 8:1327–36. doi: 10.1038/ncb1500
130. Palm NW, Medzhitov R. Pattern recognition receptors and
control of adaptive immunity. Immunol Rev. (2009) 227:221–
33. doi: 10.1111/j.1600-065X.2008.00731.x
131. Keestra AM, Winter MG, Auburger JJ, Frassle SP, Xavier MN, Winter SE,
et al. Manipulation of small Rho GTPases is a pathogen-induced process
detected by NOD1. Nature. (2013) 496:233–7. doi: 10.1038/nature12025
132. Viala J, Chaput C, Boneca IG, Cardona A, Girardin SE, Moran AP, et al.
Nod1 responds to peptidoglycan delivered by the Helicobacter pylori cag
pathogenicity island. Nat Immunol. (2004) 5:1166–74. doi: 10.1038/ni1131

Frontiers in Immunology | www.frontiersin.org

11

October 2019 | Volume 10 | Article 2441

Negi et al.

Microbiota in Generation of Innate Memory

154. Minton K. ILC3s take control in small intestine. Nat Rev Immunol. (2019)
19:353. doi: 10.1038/s41577-019-0166-z
155. Miani M, Le Naour J, Waeckel-Enee E, Verma SC, Straube M, Emond P, et
al. Gut microbiota-stimulated innate lymphoid cells support β-Defensin 14
expression in pancreatic endocrine cells, preventing autoimmune diabetes.
Cell Metab. (2018) 28:557–572.e6. doi: 10.1016/j.cmet.2018.06.012
156. Satoh-Takayama N, Vosshenrich CA, Lesjean-Pottier S, Sawa S, Lochner M,
Rattis F, et al. Microbial flora drives interleukin 22 production in intestinal
NKp46+ cells that provide innate mucosal immune defense. Immunity.
(2008) 29:958–70. doi: 10.1016/j.immuni.2008.11.001
157. Sanos SL, Bui VL, Mortha A, Oberle K, Heners C, Johner C, et al.
RORgammat and commensal microflora are required for the differentiation
of mucosal interleukin 22-producing NKp46+ cells. Nat Immunol. (2009)
10:83–91. doi: 10.1038/ni.1684
158. Vonarbourg C, Mortha A, Bui VL, Hernandez PP, Kiss EA,
Hoyler T, et al. Regulated expression of nuclear receptor
RORgammat confers distinct functional fates to NK cell receptorexpressing RORgammat(+) innate lymphocytes. Immunity. (2010)
33:736–51. doi: 10.1016/j.immuni.2010.10.017
159. Crellin NK, Trifari S, Kaplan CD, Satoh-Takayama N, Di Santo JP,
Spits H. Regulation of cytokine secretion in human CD127(+) LTi-like
innate lymphoid cells by Toll-like receptor 2. Immunity. (2010) 33:752–
64. doi: 10.1016/j.immuni.2010.10.012
160. Goto Y, Kiyono H. Epithelial barrier: an interface for the crosscommunication between gut flora and immune system. Immunol Rev. (2012)
245:147–63. doi: 10.1111/j.1600-065X.2011.01078.x
161. Levy M, Blacher E, Elinav E. Microbiome, metabolites and host immunity.
Curr Opin Microbiol. (2017) 35:8–15. doi: 10.1016/j.mib.2016.10.003
162. Bouskra D, Brezillon C, Berard M, Werts C, Varona R, Boneca IG, et al.
Lymphoid tissue genesis induced by commensals through NOD1 regulates
intestinal homeostasis. Nature. (2008) 456:507–10. doi: 10.1038/nature07450
163. Bain CC, Mowat AM. Intestinal macrophages - specialised
adaptation to a unique environment. Eur J Immunol. (2011)
41:2494–8. doi: 10.1002/eji.201141714
164. Varol C, Zigmond E, Jung S. Securing the immune tightrope: mononuclear
phagocytes in the intestinal lamina propria. Nat Rev Immunol. (2010)
10:415–26. doi: 10.1038/nri2778

Frontiers in Immunology | www.frontiersin.org

165. Jiang H, Patel PH, Kohlmaier A, Grenley MO, McEwen DG, Edgar
BA. Cytokine/Jak/Stat signaling mediates regeneration and homeostasis in
the Drosophila midgut. Cell. (2009) 137:1343–55. doi: 10.1016/j.cell.2009.
05.014
166. Donohoe DR, Garge N, Zhang X, Sun W, O’Connell TM, Bunger
MK, et al. The microbiome and butyrate regulate energy metabolism
and autophagy in the mammalian colon. Cell Metab. (2011) 13:517–
26. doi: 10.1016/j.cmet.2011.02.018
167. Kaiko GE, Ryu SH, Koues OI, Collins PL, Solnica-Krezel L, Pearce EJ, et al.
The colonic crypt protects stem cells from microbiota-derived metabolites.
Cell. (2016) 167:1137. doi: 10.1016/j.cell.2016.10.034
168. Peck BCE, Shanahan MT, Singh AP, Sethupathy P. Gut microbial influences
on the mammalian intestinal stem cell niche. Stem Cells Int. (2017)
2017:5604727. doi: 10.1155/2017/5604727
169. Buchon N, Broderick NA, Chakrabarti S, Lemaitre B. Invasive
and indigenous microbiota impact intestinal stem cell activity
through multiple pathways in Drosophila. Genes Dev. (2009)
23:2333–44. doi: 10.1101/gad.1827009
170. Cronin SJ, Nehme NT, Limmer S, Liegeois S, Pospisilik JA, Schramek D, et al.
Genome-wide RNAi screen identifies genes involved in intestinal pathogenic
bacterial infection. Science. (2009) 325:340–3. doi: 10.1126/science.11
73164
171. Levy O. Innate immunity of the newborn: basic mechanisms and
clinical correlates. Nat Rev Immunol. (2007) 7:379–90. doi: 10.1038/
nri2075
Conflict of Interest: The authors declare that the research was conducted in the
absence of any commercial or financial relationships that could be construed as a
potential conflict of interest.
Copyright © 2019 Negi, Das, Pahari, Nadeem and Agrewala. This is an open-access
article distributed under the terms of the Creative Commons Attribution License (CC
BY). The use, distribution or reproduction in other forums is permitted, provided
the original author(s) and the copyright owner(s) are credited and that the original
publication in this journal is cited, in accordance with accepted academic practice.
No use, distribution or reproduction is permitted which does not comply with these
terms.

12

October 2019 | Volume 10 | Article 2441

